APAC Healthcare Weekly (January 25) – InSilico, Daiichi, Shionogi, Alteogen, HK Inno, Sun Pharma
InSilico entered outlicensing deal. Daiichi’s Enhertu got China approval for 6th indication. Shionogi will pick up Pfizer’s stake in ViiV...
529 Views
APAC Healthcare Weekly (Oct 20)- Eisai, Daiichi Sankyo, Junshi Bioscience, Akeso, Celltrion, Neuren
This insight collates key news in APAC healthcare last week. With the earnings season beginning to unfold along with major pharma and healthcare...
610 Views
Solara Active Pharma: Carving Out Ibuprofen to Recapture Margin
​Solara's Q1 FY27 net profit up 55% YoY to INR 16.3 crore, debt reduced, considering sale of loss-making Ibuprofen business, potential for margin...
177 Views
Screening the Silkroad: Small-Mid Cap High-Risk Names to Avoid: Q2 2019
The risk remains apparent - but list reduced in number over Q2 Q1-2019 Small-Mid Cap High-Risk list of stocks ( Screening the Silkroad: Small-Mid...
679 Views
Screening the Silkroad: Small-Mid Cap - Possible High-Risk Names: Q1 2019
Increasing risk apparent Q4-2018 Small-Mid Cap High-Risk screen ( Screening the Silkroad:Â Small-Mid Cap -Â High-Risk Names To Avoid Q4 2018 )...
739 Views